Genomics and global health: time for a reappraisal.
Although currently there are only a limited number of genomic technologies that are applicable to health care in the developing countries, this is unlikely to be the case in the near future. If, however, the full potential of genomics for health care is to be fulfilled, there will have to be a complete change of emphasis in education and research in the richer countries toward a more global view of disease and its consequences.
Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK. david.weatherall@imm.ox.ac.uk
David J
DJ
Weatherall
D000755:Anemia, Sickle Cell / Q000453:epidemiology / Q000235:genetics; D035843:Biomedical Research; D003906:Developing Countries; D004501:Education, Medical; D005821:Genetic Techniques; D023281:Genomics; D014943:Global Health; D006801:Humans; D007239:Infections / Q000175:diagnosis; D007391:International Cooperation; D008967:Molecular Biology; D011634:Public Health; D018581:Technology Transfer; D013789:Thalassemia / Q000453:epidemiology / Q000235:genetics; D014495:Universities